The results indicated that TLR3 protein expression was increased in patients with KIRC compared with the healthy controls in subgroup analyses based on race, gender, age, weight, tumour grade, and cancer stages (see Figure 8, all p < 0.05). This evidence concerns the gene TLR3 and neoplasm.